In Vitro Evaluation of Commercial Probiotic Products Containing Streptococcus salivarius K12 by Assessment of Probiotic Viability and Inhibitory Potency against Respiratory Pathogens

益生菌 微生物学 生物 唾液链球菌 化脓性链球菌 效力 呼吸道感染 黄色微球菌 致病菌 链球菌 细菌 体外 呼吸系统 金黄色葡萄球菌 遗传学 解剖 生物化学
作者
Medana Zamfir,Iulia-Roxana Angelescu,Silvia‐Simona Grosu‐Tudor
出处
期刊:Processes [Multidisciplinary Digital Publishing Institute]
卷期号:11 (2): 622-622 被引量:2
标识
DOI:10.3390/pr11020622
摘要

Upper respiratory infections (URI) are the most frequent illnesses, especially in children. The majority of those infections are prescribed broad-spectrum antibiotics, which are associated with various side effects and with the increase in multi-drug-resistant strains. A promising alternative approach is the administration of the probiotic strain Streptococcus salivarius K12 (SSK12) that colonizes the upper respiratory tract (URT) and produces the salivaricins A2 and B, which strongly antagonize the growth of key respiratory pathogens. However, since for food supplements no quality controls of the active probiotic ingredient are mandatory, the efficacy of commercial products containing SSK12 may vary. This study aimed to investigate the in vitro efficacy of several commercial SSK12-containing probiotics, positioned for the prevention of respiratory infections. The parameters evaluated to determine the in vitro efficacy included the viability of the probiotic bacterial strain and the minimum inhibitory dilution (MID) of the probiotic, determined by the agar spot method, against the pathogenic/potential pathogenic bacterial strains Streptococcus pyogenes FF22 and Micrococcus luteus T18. All tests were carried out both 12 and 24 months after manufacturing (AM) for each commercial product. The viability ranged from 9 × 108 to 4.4 × 109 CFU/serving at 12 months AM and from 8.5 × 107 to 2.8 × 109 CFU/serving at 24 months AM. The MID was, in general, positively correlated with the probiotic bacterium viability and varied between the commercial products, ranging from 10−5 to 10−7 at 12 months AM and from 10−4 to 10−7 at 24 months AM. Moreover, the inhibition zones related to the two indicator strains were variable in diameter for different products. The high variation of the in vitro efficacy of commercial products containing SSK12 may explain the different results reported in the literature regarding the clinical benefits of these preparations, and the determination of this parameter may be useful to evaluate the quality of probiotic products containing this bacterial strain.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Firsterchao完成签到,获得积分0
刚刚
2秒前
2秒前
3秒前
桐桐的应助被任我采纳,获得10
3秒前
上官若男的应助被普兴强采纳,获得10
4秒前
糊涂涂完成签到,获得积分10
4秒前
null的应助被温暖砖头采纳,获得10
5秒前
陈懿完成签到,获得积分10
5秒前
5秒前
YANGTIAN完成签到,获得积分10
6秒前
6秒前
橙C发布了新的文献求助10
6秒前
6秒前
ho完成签到 ,获得积分10
7秒前
十三月的篇章完成签到,获得积分10
7秒前
7秒前
嘟噜嘟噜完成签到,获得积分10
8秒前
Miraitowa完成签到,获得积分10
8秒前
8秒前
8秒前
9秒前
152455发布了新的文献求助10
9秒前
笨笨行云的应助被何英采纳,获得20
11秒前
迷路的笑槐完成签到,获得积分10
11秒前
嘟噜嘟噜发布了新的文献求助10
11秒前
冰可乐完成签到 ,获得积分10
12秒前
13秒前
赘婿的应助被qiu采纳,获得10
14秒前
abin发布了新的文献求助10
14秒前
14秒前
wangyunhang发布了新的文献求助10
14秒前
14秒前
14秒前
15秒前
秋风的应助被小雨采纳,获得10
15秒前
琬栀完成签到,获得积分10
16秒前
莫道桑榆完成签到,获得积分10
17秒前
18秒前
普兴强发布了新的文献求助10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Markov Decision Processes and Reinforcement Learning 700
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8170973
求助须知:如何正确求助?哪些是违规求助? 9563727
关于积分的说明 21771951
捐赠科研通 7762452
什么是DOI,文献DOI怎么找? 3430786
关于科研通互助平台的介绍 2554629
邀请新用户注册赠送积分活动 2475637